Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Creswell

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Sexual Medicine|March 20, 2022
Ejaculatory Function Following Stereotactic Body Radiation Therapy for Prostate CancerTamir Sholklapper, Michael Creswell, Jonathan Cantalino, et al.
Frontiers in Oncology|April 18, 2022
Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate CancerMichael C Repka, Michael Creswell, Jonathan W Lischalk, et al.
Frontiers in Oncology|November 30, 2020
Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate CancerNima Aghdam, Abigail N Pepin, Michael Creswell, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Sexual Medicine|March 20, 2022
Ejaculatory Function Following Stereotactic Body Radiation Therapy for Prostate CancerTamir Sholklapper, Michael Creswell, Jonathan Cantalino, et al.
Frontiers in Oncology|April 18, 2022
Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate CancerMichael C Repka, Michael Creswell, Jonathan W Lischalk, et al.
Frontiers in Oncology|November 30, 2020
Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate CancerNima Aghdam, Abigail N Pepin, Michael Creswell, et al.
Pageof 2